Impact Biomedical (IBO) Non-Current Assets (2022 - 2026)

Impact Biomedical's Non-Current Assets history runs 5 years deep, the most recent figure standing at $16.7 million for Q1 2026.

• Quarterly Non-Current Assets fell 6.49% year-over-year to $16.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.6 million (down 44.27% YoY) and the FY2025 annual result came in at $17.0 million, down 4.75% from the prior year.
• Non-Current Assets was $16.7 million for Q1 2026 at Impact Biomedical, down from $17.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $46.4 million in Q4 2022 and bottomed at $16.7 million in Q1 2026.
• A 5-year average of $32.0 million and a median of $43.5 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2024 — Non-Current Assets dropped 2.38% — and 2025, when it sank 60.27%.
• Impact Biomedical's Non-Current Assets stood at $46.4 million in 2022, then decreased by 4.47% to $44.3 million in 2023, then slumped by 59.73% to $17.8 million in 2024, then decreased by 4.75% to $17.0 million in 2025, then dropped by 1.68% to $16.7 million in 2026.
• Business Quant data shows IBO's Non-Current Assets at $16.7 million in Q1 2026, $17.0 million in Q4 2025, and $17.3 million in Q3 2025.